Three-Year Clinical Outcome of Patients Treated With the Nobori Biolimus-Eluting Stent and Xience/Promus Cobalt-Chromium Everolimus-Eluting Stent for Unprotected Left Main Disease

被引：0
作者：
Hiromasa, Takashi
Kuramitsu, Shoichi
Jinnouchi, Hiroyuki
Morinaga, Takashi
Kobayashi, Yohei
Domei, Takenori
Hyodo, Makoto
Soga, Yoshimitsu
Shirai, Shinichi
Ando, Kenji
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Drug eluting stents; Coronary interventions;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15516
引用
收藏
页数：6
相关论文
共 21 条
[21]   Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents 2-Year Follow-Up of the Randomized TWENTE Trial [J].
Tandjung, Kenneth ;
Sen, Hanim ;
Lam, Ming Kai ;
Basalus, Mounir W. Z. ;
Louwerenburg, J. W. ;
Stoel, Martin G. ;
van Houwelingen, K. Gert ;
de Man, Frits H. A. F. ;
Linssen, Gerard C. M. ;
Said, Salah A. M. ;
Nienhuis, Mark B. ;
Lowik, Marije M. ;
Verhorst, Patrick M. J. ;
van der Palen, Job ;
von Birgelen, Clemens .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (24) :2406-2416
123